ALLINAIRE THERAPEUTICS, LLC

$1,498,892

from Department of Health and Human Services · National Institutes of Health

AN ANTI-EMAP II MONOCLONAL ANTIBODY AS A FIRST-IN-CLASS TREATMENT FOR GROUP III PULMONARY HYPERTENSION PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE - 1 ABSTRACT 2 3 THE KEY GOAL OF THIS DIRECT-TO-PHASE II SBIR PROPOSAL IS FOR ALLINAIRE THERAPEUTICS (ALLINAIRE) TO 4 CONDUCT IND-ENABLING STUDIES WITH A NEUTRALIZING MONOCLONAL ANTIBODY (MAB) AGAINST ENDOTHELIAL 5 MONOCYTE-ACTIVATING POLYPEP...
Description as recorded in the federal award record (cut at 400 characters).

Award ID: R44HL186831
Award type: PROJECT GRANT (B)
First obligated: Sep 9, 2026
Period starts: Sep 5, 2026
Place of performance: Cuyahoga County, Ohio 44106
Assistance listing: 93.837 CARDIOVASCULAR DISEASES RESEARCH
Amount means: Federal obligation for this grant, as of our last read Oct 13, 2026.

Open the full record on USAspending.gov More in Cuyahoga County

Copied from USAspending.gov. Where It Lands is not a government site and is not affiliated with USAspending.gov or the awarding agency.